Posted on 3/11/20
InVivo Therapeutics Closes $7M Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the closing of its previously announced public offering of 2,545,455 shares of common stock, together with . . .
Posted on 3/11/20
CVS Taking Over Grocery Chain's Pharmacies
CVS Health (NYSE:CVS) has been aggressive when it comes to expansion. That includes taking over pharmacies in existing grocery and department stores, as it's done through . . .
Posted on 3/10/20
Kala Pharmaceuticals Proposes Public Offering of Common Stock
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, announced today . . .
Posted on 3/10/20
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycles) . . .
Posted on 3/10/20
Coronavirus Concerns Have Big Pharma Working From Home
Over the past few days, health officials in Cambridge, Massachusetts, reported on a cluster of 26 cases of COVID-19 that were traced to a Biogen (NASDAQ:BIIB) . . .
Posted on 3/10/20
Lyra Therapeutics Aims For U.S. IPO In Choppy Market
SummaryLyra Therapeutics has filed to raise $57.5 million in an IPO.The firm is advancing a pipeline of treatment candidates for chronic rhinosinusitis conditions.LYRA's lead candidate is . . .
Posted on 3/9/20
CIMCON's NearSky Smart City Platform Wins 2020 BIG Innovation Award from the Business Intelligence Group
CIMCON, the leading global provider of smart city technologies, announced that the company's NearSky smart city platform is the recipient of a 2020 BIG Innovation Award . . .
Posted on 3/17/20
Trinity Life Sciences Introduces the First and Only End-to-End Market Access Solution for Biopharma
WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, announces the availability of the first and only end-to-end market access consulting solution for . . .
Posted on 3/9/20
Bayer Partners with MassBio to Launch Center for Regulatory Excellence to Support Startup Community
WHIPPANY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bayer and MassBio today announced the Center for Regulatory Excellence, a first-of-its-kind forum for startups and academia to interact with and learn . . .
Posted on 3/9/20
PerkinElmer First Quarter 2020 Financial Performance Update
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it expects first quarter 2020 revenue and . . .
Posted on 3/9/20
Trump Signs $8.3 Billion Coronavirus Funding Measure
President Donald Trump has signed an appropriations bill that allocates $8.3 billion to various arms of the federal government to fight the spread of SARS-CoV-2, the . . .
Posted on 3/9/20
Aetna Insurance Members to Receive COVID-19 Fighting Resources from CVS Health
On Friday, CVS Health (NYSE:CVS) announced some well-received news regarding its coronavirus containment efforts. Members of the conglomerate's health insurance operation, Aetna, will receive free access . . .
Posted on 3/8/20
Spero Therapeutics Announces Closing of Rights Offering
CAMBRIDGE, Mass., March 05, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high . . .
Posted on 3/8/20
Karyopharm Therapeutics Closes Public Offering of Common Stock
NEWTON, Mass., March 06, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced the closing of its previously announced registered underwritten . . .
Posted on 3/8/20
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
NEWTON, Mass., March 03, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced the pricing of its previously announced registered underwritten . . .
Posted on 3/8/20
InVivo Therapeutics Announces Pricing of $7.0 Million Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the pricing of a public offering of 2,545,455 shares of its common stock (or pre-funded warrants to . . .
Posted on 3/8/20
Mount Sinai and Harbour BioMed Collaborate
NEW YORK & CAMBRIDGE, Mass. & ROTTERDAM, Netherlands & SUZHOU, China--(BUSINESS WIRE)--Mount Sinai Health System and Harbour BioMed (HBM) have entered into a multi-year, multifaceted collaboration . . .
Posted on 3/8/20
Bioasis Announces Proposed Redemption of 15% Unsecured Debentures
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the . . .
Posted on 3/6/20
Karyopharm Therapeutics: All Systems Go
SummaryThe stock of Karyopharm Therapeutics had soared over 60% since we said to 'buy the dip' in an article last month.Late stage key trial results just . . .
Posted on 3/5/20
VBI Vaccines Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV)(VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today provided a corporate update, its outlook for . . .
Posted on 3/5/20
Is bluebird bio a Millionaire-Making Biotech?
Over the past 12 months, shares of bluebird bio (NASDAQ:BLUE) are down by 53.4% -- not exactly a performance pointing toward a millionaire-making stock, especially considering . . .
Posted on 3/5/20
Why Boston Scientific Shares Fell 10.7% in February
What happenedShares of Boston Scientific (NYSE:BSX) slipped 10.7% in February, according to data provided by S&P Global Market Intelligence, on concern supply disruptions as well as . . .
Posted on 3/4/20
This Warren Buffett-Backed Fintech Company Continues Its Impressive Growth
One of the more closely watched young players in the emerging fintech space is StoneCo (NASDAQ:STNE), the Brazilian company backed by Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) and . . .
Posted on 3/4/20
Thermo Fisher Scientific to Spend $11.5 Billion Upgrading Its DNA Testing Game
On Tuesday, Thermo Fisher Scientific (NYSE:TMO) announced its intent to acquire a leading global provider of testing technology, QIAGEN N.V. (NYSE:QGEN) for $11.5 billion. That deal . . .
Posted on 3/4/20
Why Biogen Stock Rose 14.7% in February
What happenedShares of Biogen (NASDAQ:BIIB) rose 14.7% in February, according to data provided by S&P Global Market Intelligence, after the company won a patent ruling concerning . . .

